Cleared Traditional

K130676 - AMBIO REMOTE HEALTH MONITORING SYSTEM

K130676 is an FDA 510(k) clearance for AMBIO REMOTE HEALTH MONITORING SYSTEM, manufactured by Arrayent Health, LLC D/B/A Ambio Health. The device is a Class 2 Cardiovascular device with product code DRG cleared through the Traditional 510(k) pathway after a 118-day FDA review.

K130676 · Arrayent Health, LLC D/B/A Ambio Health · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2013
Decision
118d
Days
Class 2
Risk

K130676 is an FDA 510(k) clearance for the AMBIO REMOTE HEALTH MONITORING SYSTEM. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Arrayent Health, LLC D/B/A Ambio Health (Stamford, US). The FDA issued a Cleared decision on July 8, 2013 after a review of 118 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Arrayent Health, LLC D/B/A Ambio Health devices

FDA 510(k) Submission Details - K130676

510(k) Number K130676 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 12, 2013
Decision Date July 08, 2013
Days to Decision 118 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
7d faster than avg
Panel avg: 125d · This submission: 118d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRG Device Classification - Class 2, Special Controls

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 178
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K130676.
VERIZON WIRELESS REMOTE HEALTH MANAGEMENT SYSTEM
K122458 · Cello Partnership D/B/A Verizon Wireless · Jul 2013
MEDAPPS 2.0 - REMOTE PATIENT MONITORING SYSTEM
K124000 · Medapps Inc., Dba Alere Connect · Jul 2013
CONSTANT CARE LILAH HOME HEALTH MONITORING SYSTEM - MULTI-USER VERSION
K130360 · Constant Care, LLC · Jul 2013
PHYSIOLOGICAL DATA PROCESSOR
K122763 · Zephyr Technology Corporation · Jun 2013
MODIFICATION TO INTEL-GE CARE IINOVATIONS GUIDE
K130290 · Intel-Ge Care Innovations, LLC · Jun 2013
WELLAHO PERSONALIZED OUTPATIENT MANAGEMENT SYSTEM
K123671 · Sanitas, Inc. · Jan 2013